Biotinylated Human IL-23 alpha&IL-12 beta Heterodimer Protein, His,Avitag™&Tag Free

Source : 

Biotinylated Human IL-23A&IL-12B Heterodimer Protein, His,Avitag&Tag Free (ILB-H82W6) is expressed from human 293 cells (HEK293). It contains AA Arg 20 - Pro 189 (IL23A) & Ile 23 - Ser 328 (IL12B) (Accession # Q9NPF7-1 (IL23A) & P29460-1 (IL12B)).

 

Molecule : IL23A & IL12B

 

Synonyms : IL-23 alpha & IL-12 beta

 

Format : Powder

 

Category : MABSol® Biotin Labeled Proteins

 

Accession : NP_057668.1 (IL23A) & NP_002178.2 (IL12B)

 

Storage : -20℃

 

Shipping condition : Powder,RT

 

Molecular Weight : 21.9 kDa (IL23A) & 34.7 kDa (IL12B)

 

Characteristics :

Biotinylated Human IL-23A&IL-12B Heterodimer Protein, His,Avitag&Tag Free, produced by co-expression of IL23A and IL12B, has a calculated MW of 21.9 kDa (IL23A) & 34.7 kDa (IL12B). Subunit IL23A is fused with an Avi tag (Avitag™), followed by a polyhistid

 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.

 

Buffer : PBS, pH7.4

 

Description :

Interleukin-23 subunit alpha (IL-23 alpha) can associates with IL12B to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis.

 

References :

(1) Oppmann B., et al., 2000, Immunity 13:715-725.
(2) Parham C., et al., 2002, J. Immunol. 168:5699-5708.